Over the years, GIST have been more and more precisely characterized from a molecular point of view, and thus now they are enclosed in two main categories depending on the proto-oncogene (KIT) or the platelet-derived growth factor receptor alpha gene (KIT/PDGFRA) mutations. Here, KIT is linked to gastrointestinal stromal tumor.